Skip to search boxSkip to navigationSkip to main content

Necrosis contributes to the development of hypertension in male, but not female, spontaneously hypertensive rats

*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Abstract

<p>Necrosis is a pathological form of cell death that induces an inflammatory response, and immune cell activation contributes to the development and maintenance of hypertension. Necrosis was measured in kidney, spleen, and aorta of 12- to 13-week-old male and female SHRs (spontaneously hypertensive rats); male SHRs had greater renal necrotic cell death than female SHRs. Because male SHRs have a higher blood pressure (BP) and a more proinflammatory T-cell profile than female SHRs, the current studies tested the hypothesis that greater necrotic cell death in male SHRs exacerbates increases in BP and contributes to the proinflammatory T-cell profile. Male and female SHRs were randomized to receive vehicle or Necrox-5-a cell permeable inhibitor of necrosis-from 6 to 12 weeks of age or from 11 to 13 weeks of age. In both studies, Necrox-5 decreased renal necrosis and abolished the sex difference. Treatment with Necrox-5 beginning at 6 weeks of age attenuated maturation-induced increases in BP in male SHR; BP in female SHR was not altered by Necrox-5 treatment. Necrox-5 decreased proinflammatory renal T cells in both sexes, although sex differences were maintained. Administration of Necrox-5 for 2 weeks in SHR with established hypertension resulted in a small but significant decrease in BP in males with no effect in females. These results suggest that greater necrotic cell death in male SHR exacerbates maturation-induced increases in BP with age contributing to sex differences in BP. Moreover, although necrosis is proinflammatory, it is unlikely to explain sex differences in the renal T-cell profile.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1524-1531 (8 pages)

Journal (Volume, Issue Number)

Hypertension (Volume 74, Issue 6)

Publication milestones

  • Published - 12/01/2019

Publication status

Published - 12/01/2019

ISSN

0194-911X

Publication IDs

  • Scopus: 85074965807
  • PubMed: 31656095

Publication metrics

Metrics

SciVal
FWCI
0.58
SciVal
Author count
8
SciVal
citations
3
SciVal
Paper percentile
66
Fractional count
4
Fractional count
0.50
Fractional count
4
Fractional count
0.50
Fractional count
4
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
16
Citation count
15

Funding Details

This work was funded by the National Institutes of Health (R01HL127091 and P01HL134604 to J.C. Sullivan) and the American Heart Association (17EIA33410565 to J.C. Sullivan).
FundersFunding numbers
NIH
P01HL134604
NHLBI
R01HL127091
AHA
17EIA33410565